The National Community Pharmacists Association has filed a federal lawsuit against U.S. Department of Health and Human Services regulations, alleging that direct and indirect remuneration (DIR) fees are without reasonable transparency, and they conceal from patients and taxpayers the true cost of prescription drugs while driving small business neighborhood pharmacies out of business. NCPA CEO and pharmacist B. Douglas Hoey, says “60 percent of community pharmacies believe they may go out of business in the next two years.”
While Congress or the administration have rallied against higher drug manufacturing costs and reeling in fees charged by large Pharmacy Benefit Managers (PBMs), results have been slow to be materialized.
Overstock inventory is one of the biggest hindrance to your pharmacy business’s cash flow. By joining RxPost’s network of independent pharmacies, your pharmacy business can help other community pharmacies, as well as your own, monetize and optimize your inventory.
There is absolutely no upfront capital investment, you already own your inventory.
Reduce drug inventory carrying costs and immediately increase cash flow, no waiting for rebates from wholesalers or returns companies.
Focus on what matters to your pharmacy business, clinical and patient-centric services.